Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal paclitaxel in elderly patients with non-small-cell lung cancer
ChiCTR-TNC-08000226Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2007
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liposomal paclitaxel in non-small cell lung cancer (NSCLC), sponsored by West China Hospital of Sichuan University. Primary endpoints: Progression-free survival, Time to progression and 1 more. Started Jan 2007; status: completed.
02
Drugs
liposomal paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TNC-08000226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-08000226.